DYNORPHIN AND EPILEPSY
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 50 (5-6) , 557-583
- https://doi.org/10.1016/s0301-0082(96)00045-7
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in ratsLife Sciences, 1990
- Hippocampal plasticity in the kindling model of epilepsy in ratsNeuroscience Letters, 1989
- Selective kappa antagonist properties of nor-binaltorphimine in the rat mes seizure modelLife Sciences, 1989
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989
- Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticusNeuroscience Letters, 1988
- Elevation of naloxone-sensitive 3H-dihydromorphine binding in hippocampal formation of genetically epilepsy-prone ratsLife Sciences, 1988
- Two “big” dynorphins from porcine pituitaryLife Sciences, 1982
- Characterization of rimorphin, a new [Leu] enkephalin-containing peptide from bovine posterior pituitary glandsLife Sciences, 1982
- Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in ratsLife Sciences, 1980
- α-Neo-endorphin: A “big” leu-enkephalin with potent opiate activity from porcine hypothalamiBiochemical and Biophysical Research Communications, 1979